Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-20,337
Closed -$1.05M 723
2025
Q4
$1.05M Buy
20,337
+2,981
+17% +$182K 0.01% 578
2025
Q3
$1.29M Sell
17,356
-3,675
-17% -$270K 0.01% 551
2025
Q2
$1.61M Buy
21,031
+4,008
+24% +$289K 0.01% 530
2025
Q1
$1.19M Buy
17,023
+12,231
+255% +$846K 0.01% 568
2024
Q4
$293K Buy
4,792
+1,137
+31% +$74.3K ﹤0.01% 653
2024
Q3
$217K Buy
+3,655
New +$201K ﹤0.01% 672

Other funds holding NTNX

Candriam SCA's NTNX Position: Q1 2026 in Review

Candriam SCA sold out of Nutanix (NTNX) in Q1 2026, closing a stake of 20,337 shares — an estimated $1.05M sold.

Candriam SCA first reported a position in NTNX in Q3 2024 and held it in 6 quarters. The position peaked at $1.61M in Q2 2025. 538 funds tracked by Wall St. Rank hold NTNX as of Q1 2026.

  • Candriam SCA reported no remaining Nutanix position as of Q1 2026 after selling out during the quarter.
  • Candriam SCA sold 20,337 Nutanix shares in Q1 2026, an estimated $1.05M.
  • Candriam SCA first reported a position in Nutanix in Q3 2024 and held it in 6 quarters.
  • Candriam SCA's Nutanix position peaked at $1.61M in Q2 2025.
  • 538 funds tracked by Wall St. Rank held Nutanix as of Q1 2026.

Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.